Variant report
Variant | nsv470054 |
---|---|
Chromosome Location | chr4:92623064-92679356 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000165533 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs557809270 | chr4:92628834-92628835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs577697899 | chr4:92628869-92628870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs193300541 | chr4:92628876-92628877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs553989911 | chr4:92628877-92628878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs185568371 | chr4:92628887-92628888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs552853009 | chr4:92628900-92628901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs542923816 | chr4:92628902-92628903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs544764537 | chr4:92628913-92628914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs562509955 | chr4:92628952-92628953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs531753515 | chr4:92628954-92628955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs6834517 | chr4:92628957-92628958 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs141263575 | chr4:92628969-92628970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs565366732 | chr4:92628976-92628977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs527826496 | chr4:92629000-92629001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs187604414 | chr4:92629008-92629009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs566678474 | chr4:92629048-92629049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs377037260 | chr4:92629141-92629142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs191365923 | chr4:92629191-92629192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535285764 | chr4:92629226-92629227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs372917752 | chr4:92629248-92629249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs549317901 | chr4:92629258-92629259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs12642097 | chr4:92629261-92629262 | Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
23 | rs537829625 | chr4:92629273-92629274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs557508967 | chr4:92629287-92629288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs571316764 | chr4:92629364-92629365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs531612568 | chr4:92629389-92629390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs141954058 | chr4:92629390-92629391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs540379811 | chr4:92635850-92635851 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs149290964 | chr4:92635852-92635853 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs77015411 | chr4:92635854-92635855 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs187558258 | chr4:92635889-92635890 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs35583434 | chr4:92635912-92635913 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs562824221 | chr4:92635973-92635974 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs531174885 | chr4:92636004-92636005 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs550971983 | chr4:92636005-92636006 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs527764779 | chr4:92636009-92636010 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs143292831 | chr4:92636052-92636053 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs527431634 | chr4:92636065-92636066 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs552584249 | chr4:92636066-92636067 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs547575645 | chr4:92636068-92636069 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs114469325 | chr4:92636069-92636070 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs374696922 | chr4:92636095-92636096 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs192372373 | chr4:92636150-92636151 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs35385171 | chr4:92636188-92636189 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs556549545 | chr4:92636194-92636195 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs111587647 | chr4:92636198-92636199 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs78190795 | chr4:92636209-92636210 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs554376453 | chr4:92636217-92636218 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs182729650 | chr4:92636218-92636219 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs572565769 | chr4:92636254-92636255 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Parkinson disease | 20877625 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Obesity | 20622171 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 20164919 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:92628800-92629400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr4:92629000-92629400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr4:92653200-92653400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr4:92659600-92662000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr4:92661800-92662200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr4:92661800-92662400 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
7 | chr4:92662000-92662400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr4:92662200-92662400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr4:92662400-92667800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr4:92666200-92666400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
11 | chr4:92666400-92667600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
12 | chr4:92667600-92667800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
13 | chr4:92667800-92668200 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr4:92668200-92668400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr4:92676400-92677400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
16 | chr4:92677000-92678200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
17 | chr4:92677400-92679200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
18 | chr4:92677800-92680600 | Enhancers | HUVEC | blood vessel |
19 | chr4:92678200-92679800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
20 | chr4:92679000-92680200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
21 | chr4:92679200-92680600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |